InterSol
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- InterSol
- Generic name
- PLATELET ADDITIVE 3
- Manufacturer
- Fenwal, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- a00c4a93-cde2-4753-81f7-0d6fee9fb690
- SPL ID
- 77e5b3e8-957f-4c2b-b528-e3b18b2cc70e
- Version
- 2
- Effective date
- 2020-10-20
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:37:03
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN080041 | openfda.application_number | |
| brand name | InterSol | openfda.brand_name | |
| generic name | PLATELET ADDITIVE 3 | openfda.generic_name | |
| manufacturer name | Fenwal, Inc. | openfda.manufacturer_name | |
| ndc | package | 0942-9602-12 | openfda.package_ndc |
| ndc | product | 0942-9602 | openfda.product_ndc |
| ndc11 | package | 00942960212 | derived:openfda.package_ndc |
| spl id | 77e5b3e8-957f-4c2b-b528-e3b18b2cc70e | id | |
| spl set id | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | set_id | |
| unii | GR686LBA74 | openfda.unii | |
| unii | 451W47IQ8X | openfda.unii | |
| unii | B22547B95K | openfda.unii | |
| unii | 593YOG76RN | openfda.unii | |
| unii | 4550K0SC9B | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings and Precautions: • InterSol solution is NOT FOR DIRECT INTRAVENOUS INFUSION. • Do not use if particulate matter is present or if the solution is cloudy. • Do not use if the container is damaged, leaking or if there is any visible sign of deterioration. • Do not vent. • Do not reuse. Discard unused or partially used InterSol solution. • Protect from sharp objects. • Verify that the InterSol solution has been securely attached to the PAS Connector line to avoid disconnection and leaks.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions: InterSol solution is added to leukoreduced platelet concentrates after the apheresis procedure is complete. It is not for direct intravenous infusion. InterSol solution is not expected to cause adverse events other than those normally associated with platelet transfusion.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.